Coated Transjugular Intrahepatic Portosystemic Shunt Does Not Improve Thrombocytopenia in Patients with Liver Cirrhosis

@article{Barney2012CoatedTI,
  title={Coated Transjugular Intrahepatic Portosystemic Shunt Does Not Improve Thrombocytopenia in Patients with Liver Cirrhosis},
  author={Elise J. Barney and Ester Coelho Little and Richard D. Gerkin and Alberto Ramos and Jeffrey Kahn and Mark Englin Wong and Geetha Kolli and Richard A. Manch},
  journal={Digestive Diseases and Sciences},
  year={2012},
  volume={57},
  pages={2430-2437}
}
Thrombocytopenia is a common complication of chronic liver disease. The theory of portal decompression to improve thrombocytopenia due to hypersplenism has led to the study of transjugular intrahepatic portosystemic shunt (TIPS) as a potential therapy. However, there is a paucity of data and results have been conflicting. The aim of this study was to determine whether platelet counts improved in cirrhotic patients after placement of the new polytetrafluoroethylene (PTFE)-coated TIPS, developed… CONTINUE READING

5 Figures & Tables

Connections & Topics

Mentioned Connections BETA
The theory of portal decompression to improve thrombocytopenia due to hypersplenism has led to the study of transjugular intrahepatic portosystemic shunt ( TIPS ) as a potential therapy .
One - hundred twenty controls who did not undergo a TIPS procedure were matched on average for age , sex , race , model for end - stage liver disease ( MELD ) score , and etiology of liver disease .
All Topics